2.5(top 20%)
impact factor
1.9K(top 10%)
papers
38.5K(top 10%)
citations
77(top 10%)
h-index
2.5(top 20%)
impact factor
2.0K
all documents
40.4K
doc citations
114(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Glutathione levels in human tumorsBiomarkers2012438
2Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosisBiomarkers2004425
3Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancerBiomarkers2012328
4Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosusBiomarkers2012278
5F2-Isoprostanes as markers of oxidative stressin vivo: An overviewBiomarkers2005262
6Biomarkers of some pulmonary diseases in exhaled breathBiomarkers2002254
7Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypassBiomarkers2009217
8SHORT COMMUNICATION Should the use of inhibition of cholinesterases as a specific biomarker for organophosphate and carbamate pesticides be questionedBiomarkers1998210
9MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinomaBiomarkers2009204
10Do metals inhibit acetylcholinesterase (AChE)? Implementation of assay conditions for the use of AChE activity as a biomarker of metal toxicityBiomarkers2005202
11Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancerBiomarkers2010199
12The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseasesBiomarkers2015188
13Genetic metabolic polymorphisms and the risk of cancer: a review of the literatureBiomarkers1996168
14Fixed wavelength fluorescence (FF) of bile as a monitoring tool for polyaromatic hydrocarbon exposure in fish: an evaluation of compound specificity, inner filter effect and signal interpretationBiomarkers2000162
15Creatinine versus specific gravity-adjusted urinary cadmium concentrationsBiomarkers2005161
16Biosensors for biomarkers in medical diagnosticsBiomarkers2008158
17The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disordersBiomarkers2009157
18Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?Biomarkers2011155
19Dosimetry and toxicology of inhaled ultrafine particlesBiomarkers2009154
20Dioxin/polychlorinated biphenyl body burden, diabetes and endometriosis: findings in a population-based study in BelgiumBiomarkers2003152
21Biomarkers of kidney injuryBiomarkers2011151
22Metallothionein as a tool in biomonitoring programmesBiomarkers1999150
23Development of an expert system for the integration of biomarker responses in mussels into an animal health indexBiomarkers2007149
24A novel marker for assessment of liver matrix remodeling: An enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M)Biomarkers2011147
25The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smokeBiomarkers2009144
26The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysisBiomarkers2002139
27Biological half-life of cadmium in the urine of inhabitants after cessation of cadmium exposureBiomarkers2009137
28Biomarkers of effect in toads and frogsBiomarkers2003135
29Metabonomics with1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the ratBiomarkers2005135
30Biomarkers inRuditapes decussatus: a potential bioindicator speciesBiomarkers2004134
31In vitro and in vivo studies of potential biomarkers of lead and uranium contamination: lipid peroxidation, acetylcholinesterase, catalase and glutathione peroxidase activities in three non-mammalian speciesBiomarkers1996133
32Assessment of a glutathione S-transferase and related proteins in the gill and digestive gland ofMytilus edulis(L.), as potential organic pollution biomarkersBiomarkers1997132
33Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicityBiomarkers2003131
34Biochemical markers and the FDA Critical Path: How biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug developmentBiomarkers2009129
35Plasma miRNA levels correlate with sensitivity to bone mineral density in postmenopausal osteoporosis patientsBiomarkers2014123
36Breath biomarkers for detection of human liver diseases: preliminary studyBiomarkers2002122
37Changes in serum pneumoproteins caused by short-term exposures to nitrogen trichloride in indoor chlorinated swimming poolsBiomarkers2002122
38Measurement of eight urinary metabolites of di(2-ethylhexyl) phthalate as biomarkers for human exposure assessmentBiomarkers2006122
39A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effectsBiomarkers2007122
40Serum soluble interleukin 2 receptor α in human cancer of adults and children: a reviewBiomarkers2008122
41Effect of cadmium on antioxidant enzyme activities and lipid peroxidation in the gills of the clamRuditapes decussatusBiomarkers2002119
42Urinary p-cresol is elevated in small children with severe autism spectrum disorderBiomarkers2011115
43Meeting-in-the-middle using metabolic profiling – a strategy for the identification of intermediate biomarkers in cohort studiesBiomarkers2011113
44Biomarkers in cancer screening, research and detection: present and future: a reviewBiomarkers2006112
45A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adultsBiomarkers2010111
46Urinary metabolites of workers exposed to nitrotoluenesBiomarkers2005110
47Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patientsBiomarkers2009110
48Effects of feeding and body weight loss on the1H-NMR-based urine metabolic profiles of male Wistar Han Rats: Implications for biomarker discoveryBiomarkers2004108
49Clinical considerations in study designs that use cotinine as a biomarkerBiomarkers2003107
50No changes in lymphocyte muscarinic receptors and platelet monoamine oxidase-B examined as surrogate central nervous system biomarkers in a Faroese children cohort prenatally exposed to methylmercury and polychlorinated biphenylsBiomarkers2009106